Sofosbuvir Active Not Recruiting Phase 4 Trials for Hepatitis C Viral Infection / Liver Cirrhosis Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02304159Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics